GENome-based therapeutic drugs for DEPression.

Trial Profile

GENome-based therapeutic drugs for DEPression.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Escitalopram; Nortriptyline
  • Indications Major depressive disorder
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Acronyms GENDEP
  • Most Recent Events

    • 14 Jul 2011 New source identified and integrated United Kingdom Clinical Research Network.
    • 01 Jul 2011 Results of an analyis investigating different subtypes as a predictor of response published in the Journal of Affective Disorders.
    • 01 Apr 2011 Results published in Pharmacogenomics Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top